Pharmaceutical Processing: Brand Name Statins Still Favored by Consumers

Pharmaceutical Processing: Brand Name Statins Still Favored by Consumers

Today Treato, a leading consumer healthcare website, revealed their first annual list of top statins. This ranking is part of a new series of drug rankings from the company. Statins are one of the most commonly used medications to treat high cholesterol and reduce the risk of heart disease. 

The U.S. Preventative Services Task Force (USPSTF) recently announced their recommendation that adults as young as 40 without a previous heart attack should consider starting a low dose statin. Merck formulations took the top two spots with Vytorin, at the top of the brand list and lovastatin, the generic for Merck's Mevacor, at the top of the generics list.  Despite generics for statins being on the market for many years, consumers are still favoring brand name statins as many brand names scored higher in overall satisfaction than generics. Among popular statins, Bristol Myers Squibb's Pravachol is the statin with the highest rate of posts discussing concerns, while lovastatin has the lowest rate.

Read more

Topics: News

Posted by

Truveris Team